| Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide D Krewski, RA Yokel, E Nieboer, D Borchelt, J Cohen, J Harry, S Kacew, ... Journal of Toxicology and Environmental Health, Part B 10 (S1), 1-269, 2007 | 1198 | 2007 |
| Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward RA Yokel, RA Wise Science 187 (4176), 547-549, 1975 | 723 | 1975 |
| The toxicology of aluminum in the brain: a review RA Yokel | 711 | 2000 |
| Aluminium toxicokinetics: an updated minireview RA Yokel, PJ McNamara Pharmacology & Toxicology: MiniReview 88 (4), 159-167, 2001 | 491 | 2001 |
| Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats RA Yokel, RA Wise Psychopharmacology 48, 311-318, 1976 | 466 | 1976 |
| Both positive reinforcement and conditioned aversion from amphetamine and from apomorphine in rats RA Wise, RA Yokel, H deWit Science 191 (4233), 1273-1275, 1976 | 393 | 1976 |
| Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide … CC Willhite, NA Karyakina, RA Yokel, N Yenugadhati, TM Wisniewski, ... Critical reviews in toxicology 44 (sup4), 1-80, 2014 | 380 | 2014 |
| Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice MO Oyewumi, RA Yokel, M Jay, T Coakley, RJ Mumper Journal of Controlled Release 95 (3), 613-626, 2004 | 371 | 2004 |
| Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature L Chen, RA Yokel, B Hennig, M Toborek Journal of Neuroimmune Pharmacology 3, 286-295, 2008 | 340 | 2008 |
| Manufactured aluminum oxide nanoparticles decrease expression of tight junction proteins in brain vasculature L Chen, RA Yokel, B Hennig, M Toborek Journal of Neuroimmune Pharmacology 3, 286-295, 2008 | 340 | 2008 |
| Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration RA Yokel Journal of Alzheimer's Disease 10 (2-3), 223-253, 2006 | 330 | 2006 |
| Engineered nanomaterials: exposures, hazards, and risk prevention RA Yokel, RC MacPhail Journal of occupational medicine and toxicology 6, 1-27, 2011 | 304 | 2011 |
| Aluminum chelation principles and recent advances RA Yokel Coordination Chemistry Reviews 228 (2), 97-113, 2002 | 238 | 2002 |
| Intravenous self-administration: response rates, the effects of pharmacological challenges, and drug preference RA Yokel Methods of assessing the reinforcing properties of abused drugs, 1-33, 1987 | 217 | 1987 |
| Amphetamine-type reinforcement by dopaminergic agonists in the rat RA Yokel, RA Wise Psychopharmacology 58, 289-296, 1978 | 216 | 1978 |
| Drug level of d- and l-amphetamine during intravenous self-administration RA Yokel, R Pickens Psychopharmacologia 34, 255-264, 1974 | 209 | 1974 |
| Manganese distribution across the blood–brain barrier: I. Evidence for carrier-mediated influx of manganese citrate as well as manganese and manganese transferrin JS Crossgrove, DD Allen, BL Bukaveckas, SS Rhineheimer, RA Yokel Neurotoxicology 24 (1), 3-13, 2003 | 205 | 2003 |
| Self-administration of optical isomers of amphetamine and methylamphetamine by rats RA Yokel, R Pickens Journal of Pharmacology and Experimental Therapeutics 187 (1), 27-33, 1973 | 203 | 1973 |
| Aluminum bioavailability from basic sodium aluminum phosphate, an approved food additive emulsifying agent, incorporated in cheese RA Yokel, CL Hicks, RL Florence Food and chemical toxicology 46 (6), 2261-2266, 2008 | 200 | 2008 |
| Aluminium and Alzheimer's Disease: The science that describes the link C Exley Elsevier, 2001 | 196 | 2001 |
